DIVIS LABORATORIES
Quarterly Results Analysis [Sep2023]
DIVIS LABORATORIES Quarterly Results
Consolidated | Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
Dec2021 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹1,909 Cr | ₹1,778 Cr | ₹1,951 Cr | ₹1,708 Cr | ₹1,855 Cr | ₹2,255 Cr | ₹2,518 Cr | ₹2,493 Cr |
Expenses | ₹1,430 Cr | ₹1,274 Cr | ₹1,463 Cr | ₹1,299 Cr | ₹1,234 Cr | ₹1,407 Cr | ₹1,414 Cr | ₹1,396 Cr |
Operating Income | ₹479 Cr | ₹504 Cr | ₹488 Cr | ₹408 Cr | ₹621 Cr | ₹848 Cr | ₹1,104 Cr | ₹1,097 Cr |
Other Income | ₹86 Cr | ₹81 Cr | ₹66 Cr | ₹114 Cr | ₹80 Cr | ₹88 Cr | ₹52 Cr | ₹17 Cr |
Interest | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹95 Cr | ₹93 Cr | ₹87 Cr | ₹87 Cr | ₹86 Cr | ₹84 Cr | ₹81 Cr | ₹80 Cr |
Profit Before Tax | ₹469 Cr | ₹492 Cr | ₹466 Cr | ₹436 Cr | ₹615 Cr | ₹852 Cr | ₹1,076 Cr | ₹1,034 Cr |
Profit After Tax | ₹348 Cr | ₹356 Cr | ₹321 Cr | ₹307 Cr | ₹493 Cr | ₹702 Cr | ₹895 Cr | ₹902 Cr |
EPS | ₹13.13 | ₹13.43 | ₹12.09 | ₹11.56 | ₹18.60 | ₹26.45 | ₹33.70 | ₹33.99 |
Industry Peers & Returns | 1W | 1M | 1Y |
DIVIS LABORATORIES | -1.4% | 6.6% | 9.4% |
SUN PHARMACEUTICAL INDUSTRIES | 1% | 7.9% | 18.5% |
CIPLA | -0.5% | 0.1% | 8.9% |
DR REDDYS LABORATORIES | -1% | 7.3% | 29.2% |
TORRENT PHARMACEUTICALS | -2.3% | 5.9% | 27.9% |
ABBOTT INDIA | -2.9% | -0.9% | 12.5% |
ZYDUS LIFESCIENCES | -0.4% | 8.7% | 54% |
ALKEM LABORATORIES | 0.1% | 23.7% | 48.7% |
LUPIN | -2.9% | 3.6% | 63.4% |
DIVIS LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 7.37 % |
Y-o-Y | 2.91 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2023 | ₹1,909 Cr | 7.37 | |
Jun2023 | ₹1,778 Cr | -8.86 | |
Mar2023 | ₹1,951 Cr | 14.24 | |
Dec2022 | ₹1,708 Cr | -7.94 | |
Sep2022 | ₹1,855 Cr | -17.74 | |
Jun2022 | ₹2,255 Cr | -10.46 | |
Mar2022 | ₹2,518 Cr | 1.01 | |
Dec2021 | ₹2,493 Cr | - |
DIVIS LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -4.96 % |
Y-o-Y | -22.87 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2023 | ₹479 Cr | -4.96 | |
Jun2023 | ₹504 Cr | 3.37 | |
Mar2023 | ₹488 Cr | 19.43 | |
Dec2022 | ₹408 Cr | -34.25 | |
Sep2022 | ₹621 Cr | -26.77 | |
Jun2022 | ₹848 Cr | -23.22 | |
Mar2022 | ₹1,104 Cr | 0.66 | |
Dec2021 | ₹1,097 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -11.50 % |
Y-o-Y | -25.06 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2023 | 25.09% | -11.50 | |
Jun2023 | 28.35% | 13.45 | |
Mar2023 | 24.99% | 4.52 | |
Dec2022 | 23.91% | -28.58 | |
Sep2022 | 33.48% | -10.98 | |
Jun2022 | 37.61% | -14.23 | |
Mar2022 | 43.85% | -0.36 | |
Dec2021 | 44.01% | - |
DIVIS LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -2.25 % |
Y-o-Y | -29.41 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2023 | ₹348 Cr | -2.25 | |
Jun2023 | ₹356 Cr | 10.91 | |
Mar2023 | ₹321 Cr | 4.62 | |
Dec2022 | ₹307 Cr | -37.77 | |
Sep2022 | ₹493 Cr | -29.77 | |
Jun2022 | ₹702 Cr | -21.53 | |
Mar2022 | ₹895 Cr | -0.84 | |
Dec2021 | ₹902 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -8.94 % |
Y-o-Y | -31.41 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2023 | 18.23 % | -8.94 | |
Jun2023 | 20.02 % | 21.70 | |
Mar2023 | 16.45 % | -8.46 | |
Dec2022 | 17.97 % | -32.39 | |
Sep2022 | 26.58 % | -14.62 | |
Jun2022 | 31.13 % | -12.36 | |
Mar2022 | 35.52 % | -1.85 | |
Dec2021 | 36.19 % | - |
DIVIS LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -2.23 % |
Y-o-Y | -29.41 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2023 | ₹13.13 | -2.23 | |
Jun2023 | ₹13.43 | 11.08 | |
Mar2023 | ₹12.09 | 4.58 | |
Dec2022 | ₹11.56 | -37.85 | |
Sep2022 | ₹18.6 | -29.68 | |
Jun2022 | ₹26.45 | -21.51 | |
Mar2022 | ₹33.7 | -0.85 | |
Dec2021 | ₹33.99 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
DR REDDYS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD vs ABBOTT INDIA LTD
